Pentastarch

DB09111ApprovedWithdrawnSmall moleculePlasma Substitutes

Pentastarch is a plasma volume expander used as an adjunct in the management of shock due to hemorrhage, surgery, sepsis, burns or other trauma. Pentastarch is an artificial colloid (hydroxyethyl starch derivative).

Primary indication
The primary intended use of pentastarch is as a substitute for older colloids such as albumin or hetastarch for use in plasma volume expansion.Curator reviewed · 1 structured indication
First approval
Canada, 2001
Code names
ASL 607

Resolves to

Clinical / RWD

What you can answer from here — as of March 06, 2025

733Drug interactionsStructured to mechanism, not free text
Sign in
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1Structured indicationCondition, population, route and combination as fields, not prose
Sign in
2Marketed productsAcross 2 countries and 2 labellers
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which other approved drugs treat the same conditions as Pentastarch, and which companies have late-stage candidates in those indications?

Create a free account or log in to explore the full data card.

Create Account